Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
49,060,631
-
Share change
-
-1,899,437
-
Total reported value
-
$94,190,873
-
Price per share
-
$1.92
-
Number of holders
-
83
-
Value change
-
-$22,033,163
-
Number of buys
-
42
-
Number of sells
-
44
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2018
As of 31 Dec 2018,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,060,631 shares.
The largest 10 holders included
Consonance Capital Management LP, BlackRock Inc., Broadfin Capital, LLC, Vanguard Group Inc, MORGAN STANLEY, BAKER BROS. ADVISORS LP, MANGROVE PARTNERS, STATE STREET CORP, ARMISTICE CAPITAL, LLC, and NORTHERN TRUST CORP.
This page lists
83
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.